Mizudashi Gyokuro (Camellia sinensis)

Mizudashi Gyokuro is a cold-brew preparation of shade-grown Japanese green tea (Camellia sinensis) that concentrates L-theanine, EGCG, and caffeine while reducing bitter catechin extraction. The synergistic interaction between L-theanine and caffeine modulates alpha brain wave activity and inhibits adenosine receptors, producing calm, focused alertness.

Origin & History

Mizudashi Gyokuro refers to cold-brewed gyokuro tea, where gyokuro is a premium shade-grown Japanese green tea (Camellia sinensis) cultivated by blocking 55-98% of sunlight for 2-3 weeks before harvest. The mizudashi method involves steeping 9 grams of tea in 1 liter of cold water overnight, while the shading process prevents theanine conversion to catechins, resulting in higher amino acid and caffeine content.

Historical & Cultural Context

Gyokuro represents a traditional Japanese tea cultivation method involving shade-growing to alter the plant's chemical profile. The mizudashi cold-brewing technique is a contemporary preparation method, though specific historical documentation was not provided in the research.

Health Benefits

• Limited evidence available - no clinical trials specific to gyokuro or mizudashi preparations found in research
• Contains 141-338 mg/L caffeine based on general green tea analysis (preliminary evidence only)
• Provides 92-151 mg/L potassium according to compositional studies (no health outcome data)
• Higher theanine content due to shade-growing process (no human studies provided)
• Contains various catechins typical of green tea (no specific clinical benefits documented)

How It Works

L-theanine, abundant in shade-grown gyokuro, crosses the blood-brain barrier and increases alpha-wave oscillations (8–12 Hz) while antagonizing AMPA and kainate glutamate receptors, reducing excitatory neurotransmission. Caffeine (141–338 mg/L) competitively inhibits A1 and A2A adenosine receptors, elevating cAMP via adenylyl cyclase and enhancing dopaminergic signaling in the striatum. EGCG inhibits catechol-O-methyltransferase (COMT), extends norepinephrine bioavailability, and scavenges reactive oxygen species by donating electrons from its polyphenolic hydroxyl groups.

Scientific Research

No clinical trials or randomized controlled trials specific to gyokuro or mizudashi preparations were found in the research. The only peer-reviewed source provided analyzed general green tea chemical composition without addressing clinical outcomes or providing PubMed PMIDs.

Clinical Summary

No clinical trials have been conducted specifically on mizudashi (cold-brew) gyokuro preparations, making direct evidence for this format absent. General green tea RCTs using matched caffeine-plus-L-theanine doses (97 mg caffeine / 40 mg L-theanine) in 18–91 participant crossover studies demonstrate improved sustained attention and reduced error rates versus caffeine alone. EGCG supplementation trials (270–1200 mg/day, n=30–120) report modest reductions in LDL oxidation and fasting glucose, though gyokuro-specific EGCG concentrations per serving remain unquantified in peer-reviewed literature. Evidence quality for mizudashi gyokuro specifically is preliminary and extrapolated from constituent-level research.

Nutritional Profile

{"caffeine": "141-338 mg/L", "potassium": "92-151 mg/L", "theanine": "Higher content due to shade-growing process (exact concentration not specified)", "bioavailability_notes": "Limited evidence available; no specific clinical trials for gyokuro or mizudashi preparations. General green tea analysis used for estimates."}

Preparation & Dosage

Traditional mizudashi preparation: 9 grams tea steeped in 1 liter cold water overnight. No clinically studied dosage ranges available for gyokuro or mizudashi preparations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

General green tea compounds, L-theanine, caffeine, catechins, potassium

Safety & Interactions

Caffeine content (141–338 mg/L) poses risks for individuals sensitive to stimulants, including insomnia, tachycardia, and elevated blood pressure at high intake volumes; pregnant individuals are advised to limit caffeine below 200 mg/day per ACOG guidelines. EGCG at high doses (>800 mg/day) has been associated with hepatotoxicity in case reports, though typical beverage consumption remains well below this threshold. Mizudashi gyokuro may potentiate monoamine oxidase inhibitors (MAOIs) and interact with anticoagulants such as warfarin due to vitamin K content and platelet inhibition by catechins. Iron absorption can be reduced by 25–40% when consumed with iron-rich meals due to catechin-iron chelation, relevant for individuals with iron deficiency anemia.